Hye Young Wang

Title: Hye Young Wang - Innovator in Breast Cancer Drug Screening

Hye Young Wang is an inventor based in Gunsan-si, Jeollabuk-do, South Korea. She has made significant contributions to the field of medical diagnostics, particularly in breast cancer detection and treatment. Her innovative approach focuses on the development of a method that enhances the accuracy of breast cancer drug screening tests.

Latest Patent Applications: Hye Young Wang's notable patent application is titled "Quantitative Reverse Transcription Polymerase Chain Reaction Kit for Breast Cancer Drug Screening Test and Early Diagnosis Using Tissue and Blood." This application outlines a method for breast cancer drug screening that includes several key steps. The process involves separating full-length RNA from cells obtained from tissue or blood of suspected cancer patients. Following this, a complementary DNA (cDNA) is synthesized from the full-length RNA. The method then performs a polymerase chain reaction (PCR) using a composition that includes sets of primers and probes. Each set is capable of amplifying specific markers such as human epidermal growth factor receptor 2 (HER2), cytokeratin 19, EpCAM, hTERT, Ki67, vimentin, and GAPDH. The final step compares the amount of amplification with the expression levels found in normal individuals.

Conclusion: Hye Young Wang's work represents a significant advancement in the early diagnosis and treatment of breast cancer. Her innovative methods have the potential to improve patient outcomes and contribute to the ongoing fight against this disease.